Affiliation:
1. Oncology Nursing Consultant, River Ridge, Louisiana, USA
Abstract
Abstract
Learning Objectives
After completing this course, the reader will be able to: Describe how vesicant chemotherapy drugs can extravasate from implanted ports.Recommend procedures to obtain a blood return from central venous access devices.Evaluate the signs and symptoms of a vesicant extravasation.Administer the FDA-approved vesicant extravasation treatments and antidotes.
CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Extravasation is an unusual but potentially severe complication of vesicant chemotherapy administration. Some extravasation injuries prompt litigation and the oncologist's actions, or lack of action, are scrutinized in the courtroom. This article presents advice and recommendations for treating patients who receive vesicants and includes a discussion of FDA-approved vesicant extravasation treatments and antidotes.
Publisher
Oxford University Press (OUP)
Reference16 articles.
1. Retrospective study of the management of chemotherapeutic extravasation injury;Langstein;Ann Plast Surg,2002
2. Nursing management of adriamycin extravasation;Barlock;Am J Nurs,1979
3. Intrathoracic extravasation of antineoplastic agents: Case reports and systematic review;Bozkurt;Am J Clin Oncol,2003
4. Extravasations from implanted ports;Schulmeister;Oncol Nurs Forum,2000
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献